Fiera Capital Corp purchased a new stake in The Allstate Co. (NYSE:ALL - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 2,735 shares of the insurance provider's stock, valued at approximately $519,000.
Other institutional investors also recently bought and sold shares of the company. GSA Capital Partners LLP acquired a new stake in shares of Allstate during the 1st quarter worth $566,000. Oppenheimer & Co. Inc. increased its holdings in shares of Allstate by 2.0% during the 1st quarter. Oppenheimer & Co. Inc. now owns 11,621 shares of the insurance provider's stock worth $2,011,000 after buying an additional 227 shares during the last quarter. Atomi Financial Group Inc. increased its holdings in shares of Allstate by 16.6% during the 1st quarter. Atomi Financial Group Inc. now owns 2,019 shares of the insurance provider's stock worth $349,000 after buying an additional 288 shares during the last quarter. NorthRock Partners LLC increased its holdings in shares of Allstate by 10.0% during the 1st quarter. NorthRock Partners LLC now owns 4,008 shares of the insurance provider's stock worth $693,000 after buying an additional 365 shares during the last quarter. Finally, Meeder Advisory Services Inc. increased its holdings in shares of Allstate by 13.0% during the 1st quarter. Meeder Advisory Services Inc. now owns 4,618 shares of the insurance provider's stock worth $799,000 after buying an additional 533 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Thomas J. Wilson sold 90,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Toohey sold 16,682 shares of the firm's stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the transaction, the executive vice president now owns 4,873 shares in the company, valued at $877,968.41. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 192,530 shares of company stock worth $34,967,665 over the last quarter. 1.80% of the stock is owned by company insiders.
Allstate Stock Up 1.3 %
Shares of ALL stock traded up $2.51 during trading hours on Monday, hitting $199.41. 355,831 shares of the company were exchanged, compared to its average volume of 1,545,810. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a one year low of $129.17 and a one year high of $201.00. The business's 50-day simple moving average is $189.09 and its two-hundred day simple moving average is $175.87. The stock has a market capitalization of $52.80 billion, a price-to-earnings ratio of 12.75, a P/E/G ratio of 1.76 and a beta of 0.48.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to analysts' expectations of $14.57 billion. During the same quarter last year, the company posted $0.81 earnings per share. The company's quarterly revenue was up 14.7% compared to the same quarter last year. Sell-side analysts predict that The Allstate Co. will post 15.34 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ALL. Barclays upped their price target on shares of Allstate from $175.00 to $187.00 and gave the stock an "underweight" rating in a research report on Thursday, October 31st. UBS Group upped their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. Keefe, Bruyette & Woods upped their price target on shares of Allstate from $222.00 to $225.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 6th. Piper Sandler upped their price target on shares of Allstate from $188.00 to $196.00 and gave the stock an "overweight" rating in a research report on Friday, August 16th. Finally, Jefferies Financial Group upped their price target on shares of Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a research report on Friday. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate currently has a consensus rating of "Moderate Buy" and an average price target of $212.56.
Check Out Our Latest Analysis on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.